Why C.H Robinson Stock Was Tumbling Today

CHRW dropped 12.7% after announcing a $5.8 billion stock-and-cash acquisition of RXO, while RXO surged 21.9%. The split reaction shows the market rewarding the target and punishing the buyer.

CHRW expects $300 million in annual cost synergies from the combination. Investors focused elsewhere. The deal adds roughly $3 billion in new debt at CHRW, and the company is pausing share buybacks to manage the balance sheet.

Interpretation: the sell-off suggests traders weigh the leverage and the loss of buyback support more heavily than the projected synergies. The $300 million synergy figure may not have been enough to offset concerns about financing a deal of this size, though the source does not show how investors valued those savings.

For RXO, the 21.9% jump reflects the premium embedded in the offer. Because part of the consideration is stock, RXO's price now carries exposure to CHRW's performance, which is a reason the two tickers may trade in tandem until the deal closes. That linkage is an inference from the stock-and-cash structure, not a stated feature of the terms.